You have free access to this content

Basic and Applied Pathology

Cover image for Vol. 5 Issue 4

Edited By: Professor Jeong-Wook Seo

Online ISSN: 1755-9294



Author Guidelines


Thank you for your interest in Basic and Applied Pathology (BAAP). Please consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. We are looking forward to your submission.


Maximize the discoverability of your research. Online access to BAAP is currently FREE to readers!


TABLE OF CONTENTS
1. Aims and Scope
2. Review Process
3. Manuscript Categories
4. Disclosure
5. Ethical Considerations
6. Randomized Controlled Trials
7. Copyright
8. Style of Manuscripts
9. Structure of Manuscripts
10. Supplementary Material
11. Submission of Manuscripts
12. Proofs
13. Offprints
14. Tracking Manuscripts
15. Early View
16. BAAP Online
17. Editorial Office address

1. AIMS AND SCOPE
Basic and Applied Pathology is designed for the timely communication of peer-reviewed studies which provide significant new information or insights into the pathology of the human and animals. Contributions are reviewed and selected by a group of distinguished referees from around the world, some of whom constitute the journal's Editorial Board. The journal covers the basic biological science research, hospital pathology, legal pathology, veterinary pathology and toxicological studies. Studies may be in any field of experimental, anatomic, or clinical pathology, including molecular pathology. Regional representation will be a key feature of BAAP and we will facilitate fair collaboration among different disciplines within pathology and among different countries. International collaborative and comparative studies are encouraged particularly among states from the Asia Pacific region. Case reports are published only if they provide new insights into disease mechanisms or new information.

BAAP is a joint publication of Societies of Pathology from Asia Pacific Countries and founding member societies (in alphabetical order) include the: The Korean Society for Cytopathology, The Korean Society for Legal Medicine, The Korean Society of Oral and Maxillofacial Pathology, The Korean Society of Pathologists, The Korean Society of Toxicological Pathology, The Korean Society of Veterinary Pathology.

Frequency: Quarterly


2. REVIEW PROCESS
Manuscripts are assigned sequentially to Associate Editors. An Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors. A decision is made usually within six weeks of the receipt of the manuscript.

The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised or is rejected. Minor revisions are expected to be returned within four weeks of decision; major revisions within three months. Manuscripts not revised within these time periods are subject to withdrawal from consideration for publication unless the authors can provide extenuating circumstances.

A number of manuscripts will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editor find it inappropriate for publication in the Journal. Similarly, the Editors may expedite the review process for manuscripts felt to be of high priority in order to reach a rapid decision. Such ‘fast-track decisions’ will normally occur within one week of receipt of the manuscript.

Authors may provide the Editor-in-Chief with the names, addresses and email addresses of up to three suitably qualified individuals of international standing who would be competent to referee the work, although the Editor-in-Chief will not be bound by any such nomination. Likewise, authors may advise of any individual who for any reason, such as potential conflict of interest, might be inappropriate to act as a referee, again without binding the Editor-in-Chief.

The Editor-in-Chief’s decision is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief.

All journals Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication, the Editor and the Publisher reserve the right to modify manuscripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.

3. MANUSCRIPT CATEGORIES

(1) ORIGINAL ARTICLES
Word limit: 4,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured (background and aim, methods, results, conclusions).
References: no limit.
Figures/ tables: no limit, but 8 figures should be sufficient.
Description: Full-length reports of current research in either basic or clinical science.

(2) CASE REPORTS
Word limit: 1,500 words maximum including abstract but excluding references, tables and figures.
Abstract: 150 words maximum, unstructured (no sub-headers).
References: 20 maximum.
Figures/ tables: 4 maximum.
Description: Disease mechanisms or new information that provide new insights. The text should be arranged as follows: Abstract; Introduction; Case Report; Discussion. 

(3) IMAGES
Title: 10 words maximum.
Word limit: 300 words maximum.
Abstract: no abstract required for this manuscript type.
References: 5 maximum.
Figures: 2 maximum.
Description: Illustrative images which are unique or highly illustrative of specific occurrences in pathology. They will be reviewed by the Editorial Board prior to acceptance. They should be accompanied by a brief one-paragraph description of relevant clinical information.

(4) LETTERS TO THE EDITOR
Word limit: 500 words maximum.
Abstract: not required for this manuscript type.
References: 5 maximum.
Figures/ tables: 1 maximum.
Description: Letters must offer perspective to content published in B. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.

(5) COMMENTARIES [ONLY BY INVITATION OF EDITORS]
Word limit: 1,500 words maximum including abstract but excluding references.
Title: 20 words maximum.
Abstract: 45 words maximum.
References: 10 maximum, including the article discussed.
Figures/tables: 2 maximum.
Description: Commentaries discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider con-text of the field.

(6) REVIEW ARTICLES [ONLY BY INVITATION OF EDITORS]
Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum.
References: no maximum.
Figures/tables: minimum 1 image or figure.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editor. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

(7) EDITORIALS [ONLY BY INVITATION OF EDITORS]
Word Limit: 1,500 words maximum.
Abstract: no abstract required for this manuscript type.
References: 5 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.


4. DISCLOSURE
At the time of submission, the submitting author must include a disclosure statement in the body of the manuscript. The statement will describe all of the authors’ relationships with companies that may have a financial interest in the information contained in the manuscript. This information should be provided under the heading titled ‘Disclosure,’ which should appear after the ‘Methods’ section and before the ‘References’ section. The absence of any interest to disclose must also be stated. In addition, any financial interests must be detailed in the Financial Disclosure form, which will be provided to the corresponding author upon acceptance for distribution to each author.


5. ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Edinburgh 2000), available at: http://www.wma.net/e/policy/b3.htm. The journal retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies. All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).

In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.

Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.


6. RANDOMIZED CONTOLLED TRIALS
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement: http://www.consort-statement.org


7. COPYRIGHT
Papers accepted for publication in the journal become copyright of The Korean Society for Cytopathology, The Korean Society for Legal Medicine, The Korean Society of Oral and Maxillofacial Pathology, The Korean Society of Pathologists, The Korean Society of Toxicological Pathology, The Korean Society of Veterinary Pathology and Wiley-Blackwell Asia and authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright, it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the Copyright Assignment Form, and must sign the Form or agree that the corresponding author can sign on their behalf. Acceptance of a manuscript is contingent upon receipt of a signed Copyright Assignment Form. Authors can download the form at: http://www.blackwellpublishing.com/pdf/baap_CAF.pdf


8. STYLE OF THE MANUSCRIPT
Manuscripts must follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at: http://www.ICMJE.org/.
Spelling The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.
Units All measurements must be given in SI or SI-derived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website at: http://www.bipm.fr

Abbreviations Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.


9. STRUCTURE OF THE MANUSCRIPT
The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) references, (vi) supplementary material, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

TITLE PAGE
The title page should contain (i) the title of the paper. Concise titles are easier to read than long, convoluted ones. Titles that are too short may, however, lack important information, such as study design (which is particularly important in identifying randomized controlled trials). Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific. (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified. The title should be short, informative and contain the major key words so that readers and in particular online users will discover the article easily in online search. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.

ABSTRACT AND KEYWORDS
The length of abstracts must adhere to the word count specifications under the section Manuscript Categories. The abstract should state the main problem, methods, results, and conclusions. There should be no subheadings in the abstract. It must be factual and comprehensive. The use of abbreviations and acronyms should be limited and general statements (e.g. ‘‘the significance of the results is discussed’’) should be avoided.
Three to five key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at: http://www.nlm.nih.gov/mesh/meshhome.html

TEXT
Authors must use the following subheadings to divide the sections of their Original Article manuscript: Introduction, Methods, Results, Discussion, Acknowledgment, Disclosure, References, and when relevant, Supplementary Material.

ACKNOWLEDGMENTS
This should include sources of support, including federal and industry support. All authors who have contributed to the manuscript must be acknowledged. Medical writers, proofreaders and editors should not be listed as authors, but acknowledged at the beginning or end of the text.

DISCLOSURE
At the time of submission, each author must disclose and describe any involvement, financial or otherwise, that might potentially bias his or her work. Disclosure must be included in the text of the manuscript.

REFERENCES
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. A Smith, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list. Names of journals should be abbreviated in the style used in Index Medicus. Authors are responsible for the accuracy of the references.

We recommend the use of a tool such as Reference Manager for reference management and formatting.
Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp

Journal article
1. Gibas Z, Prout DF Jr, Pontes JR. Chromosome changes in germ cell tumours of the testis. Cancer Genet Cytogenet 1986; 19: 254-52.

Journal articles published ahead of issue (print or online)
2. Benz PJ, Soll J, Bölter B. Protein transport in organelles: The composition, function and regulation of the Tic complex in chloroplast protein import. FEBS Journal, 2009. doi: 10.1111/j.1742-4658.2009.06874.x

Book
3. Disaia P.J., Creasman WT. Clinical Gynecologic Oncology, 6th edn. St. Louis, Mosby: Year Book, Inc., 2002.

Chapter in a Book
4. Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995; 465–78..

TABLES
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. If tables have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

FIGURES
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration. If figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

Size: Figures should be sized to fit within the column (82 mm), intermediate (118 mm) or the full text width (173 mm).

Resolution: Figures must be supplied as high resolution saved as .eps or .tif. Halftone figures 300 dpi (dots per inch), color figures 300 dpi saved as CMYK, figures containing text 400 dpi, line figures 1,000 dpi.

Color figures: Files should be set up as CMYK (cyan, magenta, yellow, black) and not as RGB (red, green, blue) so that colors as they appear on screen will be a closer representation of how they will print in the Journal.

Line figures: Must be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package.

Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text or 8 point (Should be readable after reduction – avoid large type or thick lines). Line width between 0.5 and 1 point.

Figure legends: Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

More help on preparation of illustrations can be found at: http://authorservices.wiley.com/bauthor/digill.asp

EQUATIONS
Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics. Use the simplest possible form for all mathematical symbols.


10. SUPPLEMENTARY MATERIAL
Supplementary materials are provided by the authors to support the content of an article but they are not integral to that article. They are hosted via a link on Synergy but do not appear in the print version of the article. Supplementary materials must be submitted together with the article for review; they should not be added at a later stage. They can be in the form of tables, figures, appendices and even video footage. Reference to supplementary materials in the main body of the article is allowed. However, it should be noted that excessive reference to a piece of supplementary material may indicate that it would be better suited as a proper reference or fully included figure/table. The materials will be published as they are supplied and will not be checked or typeset in any way. All supplementary material files should come with a legend, listed at the end of the main article. Each figure and table file should not be larger than 5MB, although video files may be larger. Prior to submission, please check the guidelines at: http://authorservices.wiley.com/bauthor/suppmat.asp


11. SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/baap. Authors must supply an email address as all correspondence will be by email. Two files should be supplied: the covering letter and the manuscript (in Word or rich text format (.rtf)). The covering letter should be uploaded as a file not for review in keeping with the double-blind review process.

All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.

GENERAL
• Submissions must be double-spaced.
• All margins should be at least 30 mm.
• All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
• Do not use Enter at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β Greek beta).
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).

Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used for publication.

COVERING LETTER
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.

The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.


12. PROOFS
It is essential that corresponding authors supply an email address to which correspondence can be emailed while their article is in production. Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off by the Editor or held over to the next issue. Acrobat Reader will be required in order to read the PDF. This software can be downloaded (free of charge) from the following Web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof.


13. OFFPRINTS
Minimum orders of 50 offprints will be provided upon request, at the author's expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields. If you have queries about offprints please email offprint@cosprinters.com


14. TRACKING MANUSCRIPTS
Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. For more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more, visit: http://authorservices.wiley.com/bauthor/


15. EARLYVIEW
The journal is covered by Wiley-Blackwell’s EarlyView service. EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. EarlyView articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of EarlyView articles means that they do not yet have volume, issue or page numbers, so EarlyView articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html 


16. BAAP ONLINE
For more information, visit the journal home page at: http://www.wileyonlinelibrary.com/journal/baa3

Visit Wiley-Blackwell’s web pages for submission guidelines and digital graphics standards at:
http://authorservices.wiley.com/bauthor/journal.asp and http://authorservices.wiley.com/bauthor/digill.asp

This journal is available online at Wiley Online Library. Visit wileyonlinelibrary.com to search the articles and register for table of contents and e-mail alerts.


17. EDITORIAL OFFICE ADDRESS
Professor Jeong-Wook Seo,
Editor-in-Chief, Basic and Applied Pathology
Seoul National University
College of Medicine
Email: jwseo@snu.ac.kr

SEARCH

SEARCH BY CITATION